Drawing for CLARIO

USPTO serial 97107116

CLARIO

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
Examiner
KETCHUM, BRENDAN J
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with CLARIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Kramer

David M. Kramer Buchanan Ingersoll & Rooney, P.C.1700 K Street N.W.Suite 300Washington, DC 20006

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardshipACTIVE
042Data automation and collection service using proprietary software to evaluate, analyze and collect service data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardshipACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 27, 2026EX5GSOU EXTENSION 5 GRANTED
May 6, 2026EXT5SOU EXTENSION 5 FILED
May 6, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 2, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2026EX4GSOU EXTENSION 4 GRANTED
Nov 6, 2025EXT4SOU EXTENSION 4 FILED
Nov 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2025EX3GSOU EXTENSION 3 GRANTED
May 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 4, 2025EXT3SOU EXTENSION 3 FILED
Nov 5, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2024EX2GSOU EXTENSION 2 GRANTED
Nov 5, 2024EXT2SOU EXTENSION 2 FILED
Nov 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 23, 2024NOACCORRECTED NOA E-MAILED
Apr 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2024EX1GSOU EXTENSION 1 GRANTED
Apr 22, 2024DPCCDIVISIONAL PROCESSING COMPLETE
Apr 17, 2024IROARESPONSE TO ITU OFFICE ACTION ENTERED
Apr 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2024INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Apr 8, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 20, 2024EXT1SOU EXTENSION 1 FILED
Mar 20, 2024DRRRDIVISIONAL REQUEST RECEIVED
Mar 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED
Nov 22, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 22, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 22, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 25, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS
Sep 25, 2023OP.TOPPOSITION TERMINATED NO. 999999
Sep 25, 2023OP.DOPPOSITION DISMISSED NO. 999999
Jun 26, 2023OP.IOPPOSITION INSTITUTED NO. 999999
May 23, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED
May 22, 2023APETASSIGNED TO PETITION STAFF
May 4, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 20, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jan 3, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2022XAECEXAMINER'S AMENDMENT ENTERED
Nov 29, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Nov 29, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 25, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 25, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 13, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE
Oct 7, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2022DOCKASSIGNED TO EXAMINER
Mar 18, 2022TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 18, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED
Nov 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance